Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Krystal Biotech to Present at TD Cowen 44th Annual Health Care Conference
-
Krystal Biotech (KRYS) named 2024 Best Idea at TD Cowen
-
Krystal Biotech's (KRYS) Vyjuvek approval is "best case scenario" - PT Raised to $130 at TD Cowen
-
Krystal Biotech to Present at the 43rd Annual TD Cowen Health Care Conference
-
Cowen Reiterates Outperform Rating on Krystal Biotech (KRYS), "Remain Encouraged by New Durability Analyses"
-
Cowen Reiterates Krystal Biotech (KRYS) at Outperform, $111 PT, Encouraged by Impressive Skin Changes of KB301 Which "FDA Places Significant Weight On"
-
Krystal Biotech to Participate in Cowen’s 42nd Annual Health Care Conference
-
Krystal Biotech (KRYS) Prices 2.67M Share Offering at $75/sh
-
Krystal Biotech Announces Pricing of $200 Million Public Offering of Common Stock
-
Krystal Biotech (KRYS) Announces Proposed $200M Stock Offering
-
Krystal Biotech Announces Proposed $200 Million Public Offering of Common Stock
-
Krystal Biotech (KRYS) PT Raised to $111 at Cowen
-
Krystal Biotech to Present at the Cowen 41st Annual Health Care Conference
-
Krystal Biotech (KRYS) Prices 1.923M Share Upsized Common Offering at $65/Sh
-
Krystal Biotech Announces Pricing of Upsized $125 Million Public Offering of Common Stock
-
Krystal Biotech (KRYS) to Offer $100M in Common Stock
-
Krystal Biotech Announces Proposed $100 Million Public Offering of Common Stock
-
UPDATE: Krystal Biotech (KRYS) Prices 2.275M Share Common Offering at $55/Sh
-
Krystal Biotech Announces Pricing of $125 Million Public Offering of Common Stock
-
Krystal Biotech (KRYS) Announces Proposed Public Offering of Common Stock
-
Krystal Biotech Announces Proposed Public Offering of Common Stock
-
Krystal Biotech to Present at the Cowen 40th Annual Healthcare Conference
-
Krystal Biotech (KRYS) Highlighted As Top SMidcap Idea At Cowen
-
Krystal Biotech (KRYS) Prices 2.5M Share Common Offering at $40/Sh
-
Krystal Biotech Announces Pricing of $100.0 Million Public Offering of Common Stock
-
Krystal Biotech (KRYS) Commences $100 Million Public Offering of Common Stock
-
Krystal Biotech Announces Proposed $100 Million Public Offering of Common Stock
-
Krystal Biotech (KRYS) Enters $50M ATM Offering via Cowen
-
Krystal Biotech to Present at the Cowen and Company 39th Annual Health Care Conference
-
Cowen Starts Krystal Biotech (KRYS) at Outperform
-
Krystal Biotech Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Over-Allotment Option
-
Krystal Biotech (KRYS) Prices 3M Share Offering at $20/Sh
-
Krystal Biotech Announces Pricing of $60.0 Million Public Offering of Common Stock
-
Krystal Biotech (KRYS) Commences $60M Public Offering of Common Stoc
-
Krystal Biotech Announces Commencement of $60.0 Million Public Offering of Common Stock

